Literature DB >> 22638656

Over-expression of integrin-linked kinase correlates with aberrant expression of Snail, E-cadherin and N-cadherin in oral squamous cell carcinoma: implications in tumor progression and metastasis.

Dan Zhao1, Xiu-Fa Tang, Kai Yang, Ji-Yuan Liu, Xiang-Rui Ma.   

Abstract

Integrin-linked kinase (ILK), an intracellular protein with serine/threonine protein kinase activities, plays a key role in integrin mediated cell-excellular matrix interactions, regulating cell proliferation, apoptosis, differentiation, and migration. ILK has been implicated in the development and progression in several malignancies. However, the role of ILK and ILK-mediated epithelial-mensenchymal transition (EMT) in the progression of oral squamous cell carcinoma (OSCC) has not been well understood. Here, by immunohistochemistry, we studied the expression of ILK, Snail, E-cadherin and N-cadherin in 98 primary OSCC specimens and analyzed their correlations with clinicopathologic profiles and clinical outcome. We also investigated the expression of ILK in 42 corresponding lymph node metastases. Positive expression of ILK protein was detected in 87.8 % of the primary tumors and 100 % of metastatic lesions. Increased ILK expression was correlated strongly with enhanced tumor invasion, higher tumor grade, advanced clinical stage, positive lymph node status and increased risk of recurrence. Higher ILK expression was also observed in lymph node metastases in comparison with the corresponding primary tumor. Moreover, up-regulation of Snail and N-cadherin and down-regulation of E-cadherin correlated significantly with both ILK over-expression and tumor invasion. Patients with higher ILK expression exhibited shorter disease-free survival while those with absent E-cadherin expression exhibited shorter overall and disease-free survival. Taken together, our results suggest that ILK may have an important role in progression and metastasis of OSCC, possibly through EMT involving up-regulation of Snail and consequent aberrant expression of E-cadherin and N-cadherin. ILK should be considered as a critical prognostic indicator for patients with OSCC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22638656     DOI: 10.1007/s10585-012-9485-1

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  36 in total

1.  The mechanism of contribution of integrin linked kinase (ILK) to epithelial-mesenchymal transition (EMT).

Authors:  Dorota Gil; Dorota Ciołczyk-Wierzbicka; Joanna Dulińska-Litewka; Karolina Zwawa; James A McCubrey; Piotr Laidler
Journal:  Adv Enzyme Regul       Date:  2010-10-28

Review 2.  The role of epithelial-mesenchymal transition in oral squamous cell carcinoma and oral submucous fibrosis.

Authors:  Hu Yanjia; Jian Xinchun
Journal:  Clin Chim Acta       Date:  2007-04-29       Impact factor: 3.786

Review 3.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

4.  The importance of integrin-linked kinase in the regulation of bladder cancer invasion.

Authors:  Yoshiyuki Matsui; Kiran Assi; Osamu Ogawa; Peter A Raven; Shoukat Dedhar; Martin E Gleave; Baljinder Salh; Alan I So
Journal:  Int J Cancer       Date:  2011-05-28       Impact factor: 7.396

Review 5.  Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis.

Authors:  Jason J Christiansen; Ayyappan K Rajasekaran
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

Review 6.  Integrin-linked kinase: a cancer therapeutic target unique among its ILK.

Authors:  Gregory Hannigan; Armelle A Troussard; Shoukat Dedhar
Journal:  Nat Rev Cancer       Date:  2005-01       Impact factor: 60.716

7.  Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.

Authors:  Sung Woon Pyo; Mitsuyoshi Hashimoto; Young Sill Kim; Chang Hyen Kim; Sang Hwa Lee; Keith R Johnson; Margaret J Wheelock; Je Uk Park
Journal:  J Craniomaxillofac Surg       Date:  2007-02-12       Impact factor: 2.078

8.  Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail.

Authors:  L Hao; J R Ha; P Kuzel; E Garcia; S Persad
Journal:  Br J Dermatol       Date:  2012-05-08       Impact factor: 9.302

9.  Integrin-linked kinase regulates E-cadherin expression through PARP-1.

Authors:  Timothy R McPhee; Paul C McDonald; Arusha Oloumi; Shoukat Dedhar
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

10.  Overexpression of the integrin-linked kinase mesenchymally transforms mammary epithelial cells.

Authors:  A Somasiri; A Howarth; D Goswami; S Dedhar; C D Roskelley
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

View more
  24 in total

Review 1.  Focal adhesion complex proteins in epidermis and squamous cell carcinoma.

Authors:  Elizabeth K Duperret; Todd W Ridky
Journal:  Cell Cycle       Date:  2013-09-12       Impact factor: 4.534

2.  Tubular cell phenotype in HIV-associated nephropathy: role of phospholipid lysophosphatidic acid.

Authors:  Kamesh R Ayasolla; Partab Rai; Shai Rahimipour; Mohammad Hussain; Ashwani Malhotra; Pravin C Singhal
Journal:  Exp Mol Pathol       Date:  2015-06-14       Impact factor: 3.362

3.  Prognostic Prediction of Oral Squamous Cell Carcinoma by E-Cadherin and N-Cadherin Expression in Overall Cells in Tumor Nests or Tumor Cells at the Invasive Front.

Authors:  Yuu Ozaki-Honda; Sachiko Seki; Mutsunori Fujiwara; Masaaki Matsuura; Shuichi Fujita; Hisazumi Ikeda; Masahiro Umeda; Takao Ayuse; Tohru Ikeda
Journal:  Cancer Microenviron       Date:  2017-11-02

4.  Overexpression of integrin-linked kinase (ILK) promotes glioma cell invasion and migration and down-regulates E-cadherin via the NF-κB pathway.

Authors:  Feng Liang; Shuqin Zhang; Bing Wang; Jianwu Qiu; Yunjie Wang
Journal:  J Mol Histol       Date:  2013-09-13       Impact factor: 2.611

5.  E-cadherin expression and prognosis of oral cancer: a meta-analysis.

Authors:  Sheng-Lei Luo; Yong-Gang Xie; Zhen Li; Jia-Hai Ma; Xin Xu
Journal:  Tumour Biol       Date:  2014-02-27

6.  Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.

Authors:  Hong Shen; Jun-Li Ma; Yan Zhang; Gan-Lu Deng; Yan-Ling Qu; Xiao-Ling Wu; Jing-Xuan He; Sai Zhang; Shan Zeng
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

7.  Overexpression of integrin-linked kinase (ILK) is associated with tumor progression and an unfavorable prognosis in patients with colorectal cancer.

Authors:  Rui Li; Baolin Liu; Hongzhuan Yin; Wei Sun; Jianqiao Yin; Qi Su
Journal:  J Mol Histol       Date:  2012-10-31       Impact factor: 2.611

8.  Porphyromonas gingivalis initiates a mesenchymal-like transition through ZEB1 in gingival epithelial cells.

Authors:  Maryta N Sztukowska; Akintunde Ojo; Saira Ahmed; Anne L Carenbauer; Qian Wang; Brain Shumway; Howard F Jenkinson; Huizhi Wang; Douglas S Darling; Richard J Lamont
Journal:  Cell Microbiol       Date:  2016-01-13       Impact factor: 3.715

9.  The Role of E-Cadherin as a Prognostic Biomarker in Head and Neck Squamous Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Javad Yazdani; Mohhamad Ali Ghavimi; Elahe Jabbari Hagh; Farzin Ahmadpour
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

10.  Expression of integrin-linked kinase in adenoid cystic carcinoma of salivary glands correlates with epithelial-mesenchymal transition markers and tumor progression.

Authors:  Dan Zhao; Kai Yang; Xiu-Fa Tang; Nan-nan Lin; Ji-Yuan Liu
Journal:  Med Oncol       Date:  2013-06-01       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.